Answers are grounded in this paper and cite their sources.
Analysis shows post-infusion SCFA levels correlate with treatment response in multiple myeloma, suggesting metabolic insights.
Supplementary Figure S22 illustrates the association between post-infusion systemic short-chain fatty acid (SCFA) levels and treatment response in multiple myeloma (MM) patients. This figure analyzes serum SCFA levels at both 100 and 180 days post–CAR T-cell infusion, comparing patients who achieved complete response to those who did not.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: